Fliban 100 mg (flibanserin) is used for hypoactive sexual desire disorder (HSDD) in women, and its “success rate” is modest rather than dramatic. What clinical studies show In large clinical trials, compared with placebo: Women had about 0.4 to 0.5 additional satisfying sexual events per month Sexual desire scores improved slightly but significantly Overall improvement in “desire” was small to moderate on rating scales How many women actually feel better? Different analyses show: About 10–15% more women report a Fliban 100 mg improvement compared with placebo (depending on how “success” is defined) Many women report minimal or no noticeable change A clinical evaluation found that improvement is often rated as “minimal to small benefit” overall, not a strong libido boost for most users. Key takeaway (simple) It works for some women, but the effect is modest It is not a strong or reliable “libido booster” like Viagra is for erections Benefits are usually measured in small increases in desire or sexual activity per month Important reality check Flibanserin also has side effects like: dizziness sleepiness nausea fatigue So doctors usually prescribe it only when symptoms are significant and other causes are ruled out.